The FDA has approved Kerendia (finerenone) to reduce UACR, which is expected to slow CKD progression in adults with type 1 diabetes.

A proposed machine learning framework for metabolic dysfunction-associated steatotic liver disease may improve personalized risk prediction.

Cultural stigma and sensationalized media narratives regarding GLP-1 RAs contribute to patient drug avoidance and treatment nonadherence.

The SMFM released a special statement to offer a structured, multidisciplinary approach to managing sickle cell disease and vaso-occlusive crises during pregnancy.

All participating U.S. comprehensive cancer centers are experiencing a shortage of at least one anticancer agent, with more than 20 percent of centers currently ...

High-risk proteomic signatures for cardiometabolic disease emerge during childhood but remain modifiable through adult GLP-1 therapy.

Strict glycemic control failed to lower microvascular and macrovascular event rates, but increased hypoglycemia, in older adults with T2D.

Exocrine pancreatic insufficiency is prevalent among adults with T1D and is linked to higher hemoglobin A1c and mean glucose levels.

The FDA has accepted the Biologics License Application for SkinTE, granting it Priority Review for the treatment of Wagner grade 1 diabetic foot ulcers.

Women with a history of gestational diabetes have a significantly higher risk of developing postpartum CV and metabolic conditions.

The apparent survival advantage of overweight and obesity in colorectal cancer is attenuated when accounting for prediagnostic weight loss.

Researchers tested whether intensive physician training with role-playing can improve glycemic control in patients with type 2 diabetes.